Mesalazyna: interakcje

Mesalazyna (Lialda, Asacol, Pentasa), salicylan: 89 udokumentowanych interakcji w indeksowanych przez nas etykietach FDA i kartach informacyjnych. Poważne: 25, umiarkowane: 60, niewielkie: 4, pary, dla których etykieta nie zgłasza istotnej interakcji: 0. Każda pozycja poniżej cytuje zdanie, na którym się opiera. Ta strona leku to punkt wyjścia, a nie rozstrzygnięcie dla indywidualnej sytuacji.

Interakcje z etykiety

Poważne interakcje (25)

  • Azatioprynalek immunosupresyjnyPoważna

    If concomitant use of APRISO and azathioprine or 6-mercaptopurine cannot be avoided, monitor blood tests, including complete blood cell counts and platelet counts. (etykieta leku Mesalazyna, Interakcje z innymi lekami)

  • CelekoksybNLPZPoważna

    Intervention: The concomitant use of Celecoxib with other NSAIDs or salicylates is not recommended. (etykieta leku Celekoksyb, Interakcje z innymi lekami)

  • DiklofenakNLPZPoważna

    Intervention: The concomitant use of diclofenac with other NSAIDs or salicylates is not recommended. (etykieta leku Diklofenak, Interakcje z innymi lekami)

  • Intervention: The concomitant use of diclofenac sodium/misoprostol with other NSAIDs or salicylates is not recommended. (etykieta leku Diklofenak + mizoprostol, Interakcje z innymi lekami)

  • FenoprofenNLPZPoważna

    Intervention: The concomitant use of fenoprofen with other NSAIDs or salicylates is not recommended. (etykieta leku Fenoprofen, Interakcje z innymi lekami)

  • Fizostygminainhibitor cholinoesterazyPoważna

    Contraindications: ANTICHOLIUM ® should not be used in the presence of hypersensitivity to physostigmine salicylate, bronchial asthma, ulcers associated with tissue destruction (gangrene), coronary heart disease, constipation (mechanical obstipation), mechanical ischuria (urinary retention), hereditary form of muscle atrophy (myotonic dystrophy), closed traumatic… (etykieta leku Fizostygmina, Przeciwwskazania)

  • FlurbiprofenNLPZPoważna

    Intervention: The concomitant use of flurbiprofen with other NSAIDs or salicylates is not recommended. (etykieta leku Flurbiprofen, Interakcje z innymi lekami)

  • The concomitant use of ibuprofen with other NSAIDs or salicylates is not recommended. (etykieta leku Hydrokodon + ibuprofen, Interakcje z innymi lekami)

  • IbuprofenNLPZPoważna

    Intervention: The concomitant use of ibuprofen with other NSAIDs or salicylates is not recommended. (etykieta leku Ibuprofen, Interakcje z innymi lekami)

  • Intervention: The concomitant use of ibuprofen and famotidine tablet with other NSAIDs or salicylates is not recommended. (etykieta leku Ibuprofen + famotydyna, Interakcje z innymi lekami)

  • IndometacynaNLPZPoważna

    Intervention: The concomitant use of indomethacin with other NSAIDs or salicylates, especially diflunisal, is not recommended. (etykieta leku Indometacyna, Interakcje z innymi lekami)

  • Kwas mefenamowyNLPZPoważna

    Intervention: The concomitant use of mefenamic acid with other NSAIDs or salicylates is not recommended. (etykieta leku Kwas mefenamowy, Interakcje z innymi lekami)

  • Antacids Because the dissolution of the coating of the granules in APRISO capsules depends on pH, avoid co-administration of APRISO capsules with antacids [see Dosage and Administration (2) ] . (etykieta leku Mesalazyna, Interakcje z innymi lekami)

  • MeloksykamNLPZPoważna

    Intervention: The concomitant use of meloxicam with other NSAIDs or salicylates is not recommended. (etykieta leku Meloksykam, Interakcje z innymi lekami)

  • MerkaptopurynaantymetabolitPoważna

    If concomitant use of APRISO and azathioprine or 6-mercaptopurine cannot be avoided, monitor blood tests, including complete blood cell counts and platelet counts. (etykieta leku Mesalazyna, Interakcje z innymi lekami)

  • NaproksenNLPZPoważna

    Intervention: The concomitant use of naproxen with other NSAIDs or salicylates is not recommended. (etykieta leku Naproksen, Interakcje z innymi lekami)

  • Intervention: The concomitant use of naproxen and esomeprazole magnesium delayed-release tablets with other NSAIDs or salicylates is not recommended. (etykieta leku Naproksen + ezomeprazol, Interakcje z innymi lekami)

  • OksaprozynaNLPZPoważna

    Intervention: The concomitant use of oxaprozin with other NSAIDs or salicylates is not recommended. (etykieta leku Oksaprozyna, Interakcje z innymi lekami)

  • Omeprazol + wodorowęglan soduinhibitor pompy protonowejPoważna

    Antacids Because the dissolution of the coating of the granules in APRISO capsules depends on pH, avoid co-administration of APRISO capsules with antacids [see Dosage and Administration (2) ] . (etykieta leku Mesalazyna, Interakcje z innymi lekami)

  • Intervention: The concomitant use of ibuprofen with other NSAIDs or salicylates is not recommended. (etykieta leku Paracetamol + ibuprofen, Interakcje z innymi lekami)

  • PiroksykamNLPZPoważna

    Intervention: The concomitant use of piroxicam with other NSAIDs or salicylates is not recommended. (etykieta leku Piroksykam, Interakcje z innymi lekami)

  • ProbenecydPoważna

    In patients on probenecid the use of salicylates in either small or large doses is contraindicated because it antagonizes the uricosuric action of probenecid. (etykieta leku Probenecyd, Ostrzeżenia)

  • In patients on probenecid and colchicine the use of salicylates in either small or large doses is contraindicated because it antagonizes the uricosuric action of probenecid. (etykieta leku Probenecyd + kolchicyna, Ostrzeżenia)

  • Intervention: The concomitant use of naproxen with other NSAIDs or salicylates is not recommended. (etykieta leku Sumatryptan + naproksen, Interakcje z innymi lekami)

  • Wodorowęglan sodulek zobojętniający kwas żołądkowyPoważna

    Antacids Because the dissolution of the coating of the granules in APRISO capsules depends on pH, avoid co-administration of APRISO capsules with antacids [see Dosage and Administration (2) ] . (etykieta leku Mesalazyna, Interakcje z innymi lekami)

Umiarkowane interakcje (60)

  • AdapalenretinoidUmiarkowana

    Particular caution should be exercised in using preparations containing sulfur, resorcinol, or salicylic acid in combination with Adapalene Cream, 0.1%. (etykieta leku Adapalen, Interakcje z innymi lekami)

  • BalsalazydsalicylanUmiarkowana

    Mesalamine-Induced Acute Intolerance Syndrome: Symptoms may be difficult to distinguish from an exacerbation of ulcerative colitis; monitor for worsening symptoms; discontinue treatment if acute intolerance syndrome is suspected. (etykieta leku Balsalazyd, Ostrzeżenia i środki ostrożności)

  • Bromokryptynaagonista dopaminyUmiarkowana

    Therefore, CYCLOSET may increase the unbound fraction of other concomitantly used highly protein-bound therapies (e.g., salicylates, sulfonamides, chloramphenicol and probenecid), which may alter their effectiveness and risk for side effects. (etykieta leku Bromokryptyna, Interakcje z innymi lekami)

  • Brynzolamidinhibitor anhydrazy węglanowejUmiarkowana

    • Rare instances of acid-base alterations have occurred with high-dose salicylate therapy. (etykieta leku Brynzolamid, Interakcje z innymi lekami)

  • Nephrotoxic Agents including NSAIDs: Increased risk of nephrotoxicity; monitor for changes in renal function and mesalamine-related adverse reactions. (etykieta leku Mesalazyna, Interakcje z innymi lekami)

  • Nephrotoxic Agents including NSAIDs: Increased risk of nephrotoxicity; monitor for changes in renal function and mesalamine-related adverse reactions. (etykieta leku Mesalazyna, Interakcje z innymi lekami)

  • CyprofloksacynafluorochinolonUmiarkowana

    NSAIDs Use with caution Non-steroidal anti-inflammatory drugs (but not acetyl salicylic acid) in combination of very high doses of quinolones have been shown to provoke convulsions in pre-clinical studies and in postmarketing. (etykieta leku Cyprofloksacyna, Interakcje z innymi lekami)

  • DeksametazonkortykosteroidUmiarkowana

    The clearance of salicylates may be increased with concurrent use of corticosteroids. (etykieta leku Deksametazon, Interakcje z innymi lekami)

  • Dezogestrel + etynyloestradioldoustny środek antykoncepcyjnyUmiarkowana

    COCs have been shown to decrease plasma concentrations of acetaminophen, clofibric acid, morphine, salicylic acid, temazepam and lamotrigine. (etykieta leku Dezogestrel + etynyloestradiol, Interakcje z innymi lekami)

  • DiflunisalNLPZUmiarkowana

    Nephrotoxic Agents including NSAIDs: Increased risk of nephrotoxicity; monitor for changes in renal function and mesalamine-related adverse reactions. (etykieta leku Mesalazyna, Interakcje z innymi lekami)

  • Diklofenamidinhibitor anhydrazy węglanowejUmiarkowana

    Concomitant Use of Aspirin or Other Salicylates Carbonic anhydrase inhibitors, including KEVEYIS, can cause metabolic acidosis [see Warnings and Precautions (5.4) ] , which can increase the risk of salicylate toxicity. (etykieta leku Diklofenamid, Ostrzeżenia i środki ostrożności)

  • Dorzolamidinhibitor anhydrazy węglanowejUmiarkowana

    High-Dose Salicylate Therapy Although acid-base and electrolyte disturbances were not reported in the clinical trials with dorzolamide hydrochloride ophthalmic solution, these disturbances have been reported with oral carbonic anhydrase inhibitors and have, in some instances, resulted in drug interactions (e.g., toxicity associated with high-dose salicylate therapy). (etykieta leku Dorzolamid, Interakcje z innymi lekami)

  • Dorzolamid + tymololinhibitor anhydrazy węglanowejUmiarkowana

    High-Dose Salicylate Therapy Although acid-base and electrolyte disturbances were not reported in the clinical trials with dorzolamide hydrochloride ophthalmic solution, these disturbances have been reported with oral carbonic anhydrase inhibitors and have, in some instances, resulted in drug interactions (e.g., toxicity associated with high-dose salicylate therapy). (etykieta leku Dorzolamid + tymolol, Interakcje z innymi lekami)

  • EtodolakNLPZUmiarkowana

    Nephrotoxic Agents including NSAIDs: Increased risk of nephrotoxicity; monitor for changes in renal function and mesalamine-related adverse reactions. (etykieta leku Mesalazyna, Interakcje z innymi lekami)

  • CHCs have been shown to decrease plasma concentrations of acetaminophen, clofibric acid, morphine, salicylic acid and temazepam. (etykieta leku Etonogestrel + etynyloestradiol, Interakcje z innymi lekami)

  • Hyperventilation and Metabolic Acidosis: Sodium Phenylacetate and Sodium Benzoate Injection may cause side effects typically associated with salicylate overdose, such as hyperventilation and metabolic acidosis. (etykieta leku Fenylooctan sodu + benzoesan sodu, Ostrzeżenia i środki ostrożności)

  • Fenytoinalek przeciwdrgawkowyUmiarkowana

    …sulfaphenazole, sulfadiazine, sulfamethoxazole-trimethoprim Other Acute alcohol intake, amiodarone, chloramphenicol, chlordiazepoxide, disulfiram, estrogen, fluvastatin, isoniazid, methylphenidate, phenothiazines, salicylates, ticlopidine, tolbutamide, trazodone, warfarin Drugs that may decrease phenytoin serum levels Antacids Antacids may affect absorption of phenytoin. (etykieta leku Fenytoina, Interakcje z innymi lekami)

  • FludrokortyzonkortykosteroidUmiarkowana

    Rarely salicylate toxicity may occur in patients who discontinue steroids after concurrent high-dose aspirin therapy. (etykieta leku Fludrokortyzon, Interakcje z innymi lekami)

  • Fosfenytoinalek przeciwdrgawkowyUmiarkowana

    …sulfamethoxazole-trimethoprim Other Acute alcohol intake, amiodarone, chloramphenicol, chlordiazepoxide, disulfiram, estrogen, fluvastatin, isoniazid, methylphenidate, phenothiazines, salicylates, ticlopidine, tolbutamide, trazodone, warfarin Drugs that may decrease phenytoin serum levels Antineoplastic agents usually in combination Bleomycin, carboplatin, cisplatin,… (etykieta leku Fosfenytoina, Interakcje z innymi lekami)

  • Furosemiddiuretyk pętlowyUmiarkowana

    • Salicylates : Risk of salicylate toxicity ( 7.1 ) (etykieta leku Furosemid, Interakcje z innymi lekami)

  • Glibenklamidpochodna sulfonylomocznikaUmiarkowana

    …Interactions The hypoglycemic action of sulfonylureas may be potentiated by certain drugs including nonsteroidal anti-inflammatory agents, ACE inhibitors, disopyramide, fluoxetine, clarithromycin, and other drugs that are highly protein bound, salicylates, sulfonamides, chloramphenicol, probenecid, monoamine oxidase inhibitors, and beta adrenergic blocking agents. (etykieta leku Glibenklamid, Interakcje z innymi lekami)

  • Glimepirydpochodna sulfonylomocznikaUmiarkowana

    …steroids and androgens, cyclophosphamide, phenyramidol, guanethidine, fluconazole, sulfinpyrazone, tetracyclines, clarithromycin, disopyramide, quinolones, and those drugs that are highly protein-bound, such as fluoxetine, nonsteroidal anti-inflammatory drugs, salicylates, sulfonamides, chloramphenicol, coumarins, probenecid and monoamine oxidase inhibitors. (etykieta leku Glimepiryd, Interakcje z innymi lekami)

  • Glipizydpochodna sulfonylomocznikaUmiarkowana

    …antidiabetic agents, ACE inhibitors, angiotensin II receptor blocking agents, disopyramide, fibrates, fluoxetine, monoamine oxidase inhibitors, pentoxifylline, pramlintide, propoxyphene, salicylates, somatostatin analogs (e.g., octreotide), sulfonamide antibiotics, nonsteroidal anti-inflammatory agents, chloramphenicol, probenecid, coumarins, voriconazole, H2 receptor… (etykieta leku Glipizyd, Interakcje z innymi lekami)

  • Glipizyd + metforminapochodna sulfonylomocznikaUmiarkowana

    Glipizide: The hypoglycemic action of sulfonylureas may be potentiated by certain drugs, including nonsteroidal anti-inflammatory agents, some azoles, and other drugs that are highly protein bound, salicylates, sulfonamides, chloramphenicol, probenecid, coumarins, monoamine oxidase inhibitors, and beta-adrenergic blocking agents. (etykieta leku Glipizyd + metformina, Środki ostrożności)

  • Gryzeofulwinalek przeciwgrzybiczyUmiarkowana

    Serum salicylate concentrations may be decreased when griseofulvin is given concomitantly with salicylates. (etykieta leku Gryzeofulwina, Interakcje z innymi lekami)

  • HialuronidazaUmiarkowana

    • Large doses of salicylates, cortisone, adrenocorticotropic hormone (ACTH), estrogens or antihistamines may require larger amounts of hyaluronidase for equivalent dispersing effect ( 7.4 ) (etykieta leku Hialuronidaza, Interakcje z innymi lekami)

  • HydrokortyzonkortykosteroidUmiarkowana

    The clearance of salicylates may be increased with concurrent use of corticosteroids; this could lead to decreased salicylate serum levels or increase the risk of salicylate toxicity when corticosteroid is withdrawn. (etykieta leku Hydrokortyzon, Interakcje z innymi lekami)

  • Insulina aspartinsulinaUmiarkowana

    Drugs That May Increase the Risk of Hypoglycemia Drugs: Antidiabetic agents, ACE inhibitors, angiotensin II receptor blocking agents, disopyramide, fibrates, fluoxetine, monoamine oxidase inhibitors, pentoxifylline, pramlintide, salicylates, somatostatin analog (e.g., octreotide), and sulfonamide antibiotics. (etykieta leku Insulina aspart, Interakcje z innymi lekami)

  • Insulina degludecinsulinaUmiarkowana

    …May Increase the Risk of Hypoglycemia Drugs: Antidiabetic agents, ACE inhibitors, angiotensin II receptor blocking agents, disopyramide, fibrates, fluoxetine, monoamine oxidase inhibitors, pentoxifylline, pramlintide, salicylates, somatostatin analogs (e.g., octreotide), and sulfonamide antibiotics, GLP-1 receptor agonists, DPP-4 inhibitors, SGLT-2 inhibitors. (etykieta leku Insulina degludec, Interakcje z innymi lekami)

  • Insulina detemirinsulinaUmiarkowana

    …May Increase the Risk of Hypoglycemia Drugs: Antidiabetic agents, ACE inhibitors, angiotensin II receptor blocking agents, disopyramide, fibrates, fluoxetine, monoamine oxidase inhibitors, pentoxifylline, pramlintide, salicylates, somatostatin analogs (e.g., octreotide), and sulfonamide antibiotics, GLP-1 receptor agonists, DPP-4 inhibitors, SGLT-2 inhibitors. (etykieta leku Insulina detemir, Interakcje z innymi lekami)

  • Insulina glargineinsulinaUmiarkowana

    …May Increase the Risk of Hypoglycemia Drugs: Antidiabetic agents, ACE inhibitors, angiotensin II receptor blocking agents, disopyramide, fibrates, fluoxetine, monoamine oxidase inhibitors, pentoxifylline, pramlintide, salicylates, somatostatin analogs (e.g., octreotide), sulfonamide antibiotics, GLP-1 receptor agonists, DPP-4 inhibitors, and SGLT-2 inhibitors. (etykieta leku Insulina glargine, Interakcje z innymi lekami)

  • Insulina lisproinsulinaUmiarkowana

    Clinically Significant Drug Interactions with LYUMJEV Drugs That May Increase the Risk of Hypoglycemia Drugs: Antidiabetic agents, ACE inhibitors, angiotensin II receptor blocking agents, disopyramide, fibrates, fluoxetine, monoamine oxidase inhibitors, pentoxifylline, pramlintide, salicylates, somatostatin analogs (e.g., octreotide), and sulfonamide antibiotics. (etykieta leku Insulina lispro, Interakcje z innymi lekami)

  • …agents, Angiotensin-Converting Enzyme Inhibitors, Angiotensin II Receptor Blocking Agents, Disopyramide, Fibrates, Fluoxetine, Monoamine Oxidase Inhibitors, Pentoxifylline, Pramlintide, Salicylates, Somatostatin Analogs (e.g., octreotide), and Sulfonamide Antibiotics Prevention or Management Monitor blood glucose more frequently and modify AFREZZA dosage, as clinically… (etykieta leku Insulina ludzka krótko działająca, Interakcje z innymi lekami)

  • KetoprofenNLPZUmiarkowana

    Nephrotoxic Agents including NSAIDs: Increased risk of nephrotoxicity; monitor for changes in renal function and mesalamine-related adverse reactions. (etykieta leku Mesalazyna, Interakcje z innymi lekami)

  • KetorolakNLPZUmiarkowana

    Nephrotoxic Agents including NSAIDs: Increased risk of nephrotoxicity; monitor for changes in renal function and mesalamine-related adverse reactions. (etykieta leku Mesalazyna, Interakcje z innymi lekami)

  • Kwas acetylosalicylowyNLPZUmiarkowana

    Nephrotoxic Agents including NSAIDs: Increased risk of nephrotoxicity; monitor for changes in renal function and mesalamine-related adverse reactions. (etykieta leku Mesalazyna, Interakcje z innymi lekami)

  • Kwas acetylosalicylowy + dipirydamollek przeciwpłytkowyUmiarkowana

    Nephrotoxic Agents including NSAIDs: Increased risk of nephrotoxicity; monitor for changes in renal function and mesalamine-related adverse reactions. (etykieta leku Mesalazyna, Interakcje z innymi lekami)

  • Lewonorgestrel + etynyloestradioldoustny środek antykoncepcyjnyUmiarkowana

    Other Drugs Clinical effect Concomitant use of CHCs may decrease systemic exposure of acetaminophen, morphine, salicylic acid, and temazepam. (etykieta leku Lewonorgestrel + etynyloestradiol, Interakcje z innymi lekami)

  • Lewotyroksynahormon tarczycyUmiarkowana

    An initial increase in serum FT 4 is followed by return of FT 4 to normal levels with sustained therapeutic serum salicylate concentrations, although total T 4 levels may decrease by as much as 30%. (etykieta leku Lewotyroksyna, Interakcje z innymi lekami)

  • Liotyroninahormon tarczycyUmiarkowana

    An initial increase in serum FT4 is followed by return of FT4 to normal levels with sustained therapeutic serum salicylate concentrations, although total T4 levels may decrease by as much as 30%. (etykieta leku Liotyronina, Interakcje z innymi lekami)

  • Metolazondiuretyk tiazydowyUmiarkowana

    Salicylates And Other Non-Steroidal Anti-Inflammatory Drugs May decrease the antihypertensive effects of metolazone tablets, USP. (etykieta leku Metolazon, Interakcje z innymi lekami)

  • Metotreksatlek immunosupresyjnyUmiarkowana

    Caution should be used when NSAIDs and salicylates are administered concomitantly with lower doses of methotrexate, including XATMEP. (etykieta leku Metotreksat, Interakcje z innymi lekami)

  • MetyloprednizolonkortykosteroidUmiarkowana

    The clearance of salicylates may be increased with concurrent use of corticosteroids. (etykieta leku Metyloprednizolon, Interakcje z innymi lekami)

  • NabumetonNLPZUmiarkowana

    Nephrotoxic Agents including NSAIDs: Increased risk of nephrotoxicity; monitor for changes in renal function and mesalamine-related adverse reactions. (etykieta leku Mesalazyna, Interakcje z innymi lekami)

  • NateglinidmeglitynidUmiarkowana

    …with Nateglinide Drugs That May Increase the Blood-Glucose-Lowering Effect of Nateglinide and Susceptibility to Hypoglycemia Drugs: Nonsteroidal anti-inflammatory drugs (NSAIDs), salicylates, monoamine oxidase inhibitors, non-selective beta-adrenergic-blocking agents, anabolic hormones (e.g., methandrostenolone), guanethidine, gymnema sylvestre, glucomannan,… (etykieta leku Nateglinid, Interakcje z innymi lekami)

  • Nizatydynaantagonista receptora H2Umiarkowana

    In patients given very high doses (3,900 mg) of aspirin daily, increases in serum salicylate levels were seen when nizatidine, 150 mg b.i.d., was administered concurrently. (etykieta leku Nizatydyna, Interakcje z innymi lekami)

  • CHCs have been shown to decrease plasma concentrations of acetaminophen, clofibric acid, morphine, salicylic acid, and temazepam. (etykieta leku Norelgestromin + etynyloestradiol, Interakcje z innymi lekami)

  • Norgestrel + etynyloestradioldoustny środek antykoncepcyjnyUmiarkowana

    COCs have been shown to decrease plasma concentrations of acetaminophen, clofibric acid, morphine, salicylic acid, temazepam and lamotrigine. (etykieta leku Norgestrel + etynyloestradiol, Interakcje z innymi lekami)

  • Norgestymat + etynyloestradioldoustny środek antykoncepcyjnyUmiarkowana

    COCs have been shown to decrease plasma concentrations of acetaminophen, clofibric acid, morphine, salicylic acid, temazepam and lamotrigine. (etykieta leku Norgestymat + etynyloestradiol, Interakcje z innymi lekami)

  • Orfenadryna + kwas acetylosalicylowy + kofeinalek zwiotczający mięśnieUmiarkowana

    Nephrotoxic Agents including NSAIDs: Increased risk of nephrotoxicity; monitor for changes in renal function and mesalamine-related adverse reactions. (etykieta leku Mesalazyna, Interakcje z innymi lekami)

  • Pioglitazon + glimepirydtiazolidynodionUmiarkowana

    …steroids and androgens, cyclophosphamide, phenyramidol, guanethidine, fluconazole, sulfinpyrazone, tetracyclines, clarithromycin, disopyramide, quinolones, and those drugs that are highly protein-bound, such as fluoxetine, nonsteroidal anti-inflammatory drugs, salicylates, sulfonamides, chloramphenicol, coumarins, probenecid and monoamine oxidase inhibitors. (etykieta leku Pioglitazon + glimepiryd, Interakcje z innymi lekami)

  • PrednizolonkortykosteroidUmiarkowana

    NSAIDS, including aspirin and salicylates: Concomitant use of aspirin or other non-steroidal anti-inflammatory agents and corticosteroids increases the risk of gastrointestinal side effects. (etykieta leku Prednizolon, Interakcje z innymi lekami)

  • PrednizonkortykosteroidUmiarkowana

    NSAIDs including aspirin and salicylates: Increased risk of gastrointestinal side effects. (etykieta leku Prednizon, Interakcje z innymi lekami)

  • SalsalatNLPZUmiarkowana

    Nephrotoxic Agents including NSAIDs: Increased risk of nephrotoxicity; monitor for changes in renal function and mesalamine-related adverse reactions. (etykieta leku Mesalazyna, Interakcje z innymi lekami)

  • SulfadiazynasulfonamidUmiarkowana

    Conversely, agents such as indomethacin, probenecid and salicylates may displace sulfonamides from plasma albumin and increase the concentrations of free drug in plasma. (etykieta leku Sulfadiazyna, Interakcje z innymi lekami)

  • SulindakNLPZUmiarkowana

    Nephrotoxic Agents including NSAIDs: Increased risk of nephrotoxicity; monitor for changes in renal function and mesalamine-related adverse reactions. (etykieta leku Mesalazyna, Interakcje z innymi lekami)

  • TolmetynaNLPZUmiarkowana

    Nephrotoxic Agents including NSAIDs: Increased risk of nephrotoxicity; monitor for changes in renal function and mesalamine-related adverse reactions. (etykieta leku Mesalazyna, Interakcje z innymi lekami)

  • Torasemiddiuretyk pętlowyUmiarkowana

    Nonsteroidal Anti-Inflammatory Drugs Because torsemide and salicylates compete for secretion by renal tubules, patients receiving high doses of salicylates may experience salicylate toxicity when torsemide is concomitantly administered. (etykieta leku Torasemid, Interakcje z innymi lekami)

  • TriamcynolonkortykosteroidUmiarkowana

    The clearance of salicylates may be increased with concurrent use of corticosteroids. (etykieta leku Triamcynolon, Interakcje z innymi lekami)

  • Wortioksetynalek przeciwdepresyjnyUmiarkowana

    Coadministration of aspirin 150 mg/day with multiple daily doses of TRINTELLIX had no significant inhibitory effect on platelet aggregation or pharmacokinetics of aspirin and salicylic acid [see Clinical Pharmacology (12.3) ] . (etykieta leku Wortioksetyna, Interakcje z innymi lekami)

Wzmianki o niewielkim znaczeniu (4)

  • Enoksaparynalek przeciwzakrzepowyNiewielka

    These agents include medications such as: anticoagulants, platelet inhibitors including acetylsalicylic acid, salicylates, NSAIDs (including ketorolac tromethamine), dipyridamole, or sulfinpyrazone. (etykieta leku Enoksaparyna, Interakcje z innymi lekami)

  • EntakaponNiewielka

    In vitro studies have shown no binding displacement between entacapone and other highly bound drugs, such as warfarin, salicylic acid, phenylbutazone, and diazepam. (etykieta leku Entakapon, Środki ostrożności)

  • RepaglinidmeglitynidNiewielka

    Examples: Antidiabetic agents, ACE inhibitors, angiotensin II receptor blocking agents, disopyramide, fibrates, fluoxetine, monoamine oxidase inhibitors, nonsteroidal anti-inflammatory agents (NSAIDs), pentoxifylline, pramlintide, propoxyphene, salicylates, somatostatin analogs (e.g., octreotide), and sulfonamide antibiotics. (etykieta leku Repaglinid, Interakcje z innymi lekami)

  • SulfasalazynasulfonamidNiewielka

    Although the exact frequency of occurrence has not been determined, it has occurred in 3% of patients in controlled clinical trials of mesalamine or sulfasalazine. (etykieta leku Mesalazyna, Ostrzeżenia i środki ostrożności)

Sprawdź, jak Mesalazyna łączy się ze wszystkim, co przyjmujesz. Dodaj całą listę; wszystkie pary są sprawdzane jednocześnie.

Otwórz w wyszukiwarce

To nie jest porada medyczna. Stopień nasilenia odzwierciedla sformułowania etykiety, a nie indywidualne okoliczności. Oznaczenie „poważna” może dotyczyć połączenia stosowanego rutynowo pod nadzorem, a „niewielka” może mieć znaczenie przy dużych dawkach. Należy zapytać farmaceutę.